ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Ab Science

Ab Science (AB)

2.105
-0.01
( -0.47% )
Updated: 11:04:59

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
2.105
Bid
2.085
Ask
2.11
Volume
48,300
2.07 Day's Range 2.135
1.55 52 Week Range 4.97
Market Cap
Previous Close
2.115
Open
2.125
Last Trade
261
@
2.105
Last Trade Time
10:58:04
Financial Volume
-
VWAP
-
Average Volume (3m)
145,580
Shares Outstanding
51,071,069
Dividend Yield
-
PE Ratio
-7.84
Earnings Per Share (EPS)
-0.27
Revenue
958k
Net Profit
-13.62M

About Ab Science

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Paris, Paris, Fra
Founded
1970
Ab Science is listed in the Pharmaceutical Preparations sector of the Euronext with ticker AB. The last closing price for Ab Science was 2.12 €. Over the last year, Ab Science shares have traded in a share price range of 1.55 € to 4.97 €.

Ab Science currently has 51,071,069 shares outstanding. The market capitalization of Ab Science is 106.74 € million. Ab Science has a price to earnings ratio (PE ratio) of -7.84.

AB Latest News

AB Science communique un rectificatif sur les comptes consolidés au 31 décembre 2023

AB Science communique un rectificatif sur les comptes consolidés au 31 décembre 2023          COMMUNIQUE RECTIFICATIF COMMUNIQUE RECTIFICATIF SUR LES COMPTES CONSOLIDES AU 31 DECEMBRE 2023...

AB Science annonce ses résultats financiers annuels arrêtés au 31 décembre 2023 et présente un point sur ses activités

AB Science annonce ses résultats financiers annuels arrêtés au 31 décembre 2023 et présente un point sur ses activités          COMMUNIQUE DE PRESSE AB SCIENCE PRÉSENTE SES RÉSULTATS...

AB Science announces issuance of a European patent for masitinib in the treatment of severe mastocytosis with protection until 2036

AB Science announces issuance of a European patent for masitinib in the treatment of severe mastocytosis with protection until 2036 PRESS RELEASE AB SCIENCE ANNOUNCES ISSUANCE OF A EUROPEAN...

AB Science annonce la délivrance d’un brevet européen pour le masitinib dans le traitement de la mastocytose sévère avec une protection jusqu’en 2036

AB Science annonce la délivrance d’un brevet européen pour le masitinib dans le traitement de la mastocytose sévère avec une protection jusqu’en 2036 COMMUNIQUE DE PRESSE AB SCIENCE ANNONCE...

AB Science : A new publication in the medical journal Muscle & Nerve validates the use of the rate of decline of ALSFR-S score (ΔFS) for the design of clinical studies and the treatment choice for amyotrophic lateral sclerosis (ALS) patient

PRESS RELEASE A NEW PUBLICATION IN THE MEDICAL JOURNAL MUSCLE & NERVE VALIDATES THE USE OF THE RATE OF DECLINE OF ALSFRS-R SCORE (ΔFS) FOR THE DESIGN OF CLINICAL STUDIES AND THE TREATMENT...

AB Science : La Cour d’Appel de Paris confirme la mise hors de cause du Président Directeur Général d’AB Science, Alain Moussy, et diminue le montant de la sanction imposée à AB Science

AB Science : La Cour d’Appel de Paris confirme la mise hors de cause du Président Directeur Général d’AB Science, Alain Moussy, et diminue le montant de la sanction imposée à AB Science...

AB Science annonce un léger décalage de la publication de son rapport financier annuel 2023

AB Science annonce un léger décalage de la publication de son rapport financier annuel 2023 COMMUNIQUE DE PRESSE AB SCIENCE ANNONCE UN LEGER DECALAGE DE LA PUBLICATION DE SON RAPPORT...

AB Science announces that Health Canada has granted eligibility for reconsideration request for masitinib in ALS

AB Science announces that Health Canada has granted eligibility for reconsideration request for masitinib in ALS PRESS RELEASE AB SCIENCE ANNOUNCES THAT HEALTH CANADA HAS GRANTED ELIGIBILITY...

AB Science: New research shows that masitinib limits neuronal damage in a model of neuroimmune-driven neurodegenerative disease

AB Science: New research shows that masitinib limits neuronal damage in a model of neuroimmune-driven neurodegenerative disease PRESS RELEASE NEW RESEARCH SHOWS THAT MASITINIB LIMITS...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.0150.7177033492822.092.2952.041925412.18561062DE
40.1075.355355355361.9982.2951.8621025542.07590435DE
12-0.3-12.4740124742.4052.691.551455802.19303789DE
26-0.785-27.16262975782.894.4651.551309362.78941663DE
52-2.215-51.27314814814.324.971.551420553.01594887DE
156-13.275-86.313394018215.3816.681.551246327.03129788DE
260-2.235-51.49769585254.3421.751.551477138.70120244DE

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MGOLMGO Global Inc
$ 1.0998
(378.38%)
191.99M
MGRXMangoceuticals Inc
$ 0.9082
(258.97%)
162.31M
BDRXBiodexa Pharmaceuticals PLC
$ 2.8199
(122.04%)
87.92M
FLJFLJ Group Limited
$ 1.64
(111.07%)
14.9M
MMATMeta Materials Inc
$ 3.5201
(53.05%)
31.09M
CTNTCheetah Net Supply Chain Service Inc
$ 4.1558
(-71.84%)
9.9M
GWAVGreenwave Technology Solutions Inc
$ 0.0616
(-61.01%)
381.6M
LUXHLuxUrban Hotels Inc
$ 0.251
(-44.22%)
8.21M
CRKNCrown Electrokinetics Corporation
$ 0.1377
(-30.80%)
210.88M
PEGYPineapple Energy Inc
$ 0.133
(-30.00%)
41.49M
GWAVGreenwave Technology Solutions Inc
$ 0.0616
(-61.01%)
381.6M
CRKNCrown Electrokinetics Corporation
$ 0.1377
(-30.80%)
210.88M
MGOLMGO Global Inc
$ 1.0998
(378.38%)
191.99M
MGRXMangoceuticals Inc
$ 0.9082
(258.97%)
162.31M
AGRIAgriFORCE Growing Systems Ltd
$ 0.1617
(24.63%)
142.74M

Discussion

View Full Feed
goingUPagain goingUPagain 3 minutes ago
gonna hit 30?
AMC
Mr. Zen Mr. Zen 3 minutes ago
scheduled to have a conference call on its fourth quarter and full year 2023 results after market close on Tuesday, May 28, 2024 at 5:00 p.m. Pacific Time (8:00 p.m. Eastern Time).
FFIE
MPstock MPstock 4 minutes ago
I guess I was right when I said we would still be stuck mid year.
Very unfortunate but 100% on the company. Pathetic income.
And all the nonsense about the so called mfg facility.
I still don’t think they have one or at least not one that is operational.
SHMN
NewJerichoMan NewJerichoMan 4 minutes ago
Huazhu, which I think translates to "Green Building", has always been in the Business Plan. The R&D comes from this unit. Deng claims control of tech IP. Chinese companies are always have weird structure, which make them rife for scams. CIWM, I think, is supposed to be a go-between / house (not
ASKH
redspinelpinktopaz redspinelpinktopaz 4 minutes ago
Tenth thumbs up. Boy, I sure hope, you know what you're talking about!
LWLG
nilremerlin nilremerlin 4 minutes ago
https://mjbizdaily.com/cannabis-industry-heading-in-right-direction-business-operators-say/
AYRWF
Tahoe2468 Tahoe2468 4 minutes ago
FLJ FLJ FLJ
FLJ
B RY B RY 4 minutes ago
Oh no, the price/sky is falling, lol.https://investorshub.advfn.com/uimage/uploads/2024/5/21/xo[lk152098398489218466956410011.jpg
AGBA
trunkmonk trunkmonk 5 minutes ago
it should already be at least 4 way before today, any non FFFhoney Preferred lover/commons hater can understand, this is worth more than anyone like Ackman has calculated years ago. the earning have been coming in heavily for years after He calculated 15 to 20 something. its a diamond in the rough t
FNMA
Arnhem Arnhem 5 minutes ago
https://finance.yahoo.com/sec-filing/CETI/0001079973-24-000798_1935092?nn=1
CETI
frobinso frobinso 5 minutes ago
I believe that institutions will know that firstly, this transparency means that they are confident in the ability of EO Polymer's to seamlessly integrate. They will also know that availability on 200 mm wafers, allowing the end customer - hyperscaler, even those that are involved in their own foun
LWLG
ncstrongman ncstrongman 5 minutes ago
So what keeps you here ? Sell and move along..plenty of buyers waiting
CBIA
Monksdream Monksdream 5 minutes ago
Current Top 10
https://ih.advfn.com/markets/nasdaq/regular
manibiotech manibiotech 5 minutes ago
You will be surprised to know that we were being implied to even 13 years ago that phase 3 is being wrapped up . So looking at hindsight , sure you can say you won’t have invested 12 years ago .
NWBO
Carjockey2 Carjockey2 5 minutes ago
https://twitter.com/cocomoco1234567/status/1791937398458191912?t=gEr0ukalVW6bDM_ZlDHkVQ&s=19

Geez I think somebody wants this company especially with all the patents included..

$FSRN
FSRN
ProfitScout ProfitScout 5 minutes ago
$ACGX Profitable Holding Company with Multi-Million Dollar Real Estate Holding plus SAAS Lifestyle Hospitality Firm
 
 Impressive Revenue Growth and Profitable Expansion: Alliance Creative Group, Inc. (ACGX)

https://www.thechicagodispatch.com/article/711197151-profitable
ACGX
Sorbytech Sorbytech 5 minutes ago
The company hasnt dissolved. Thats American Green CBD, not American Green itself.
ERBB
Poundthetable Poundthetable 6 minutes ago
Good day to buy the heck out of this~
NSAV
Volcano Volcano 6 minutes ago
NKGN

moving up again in anticipation of 05/23 presentation for cancer tumor data
NKGN
learningcurve2020 learningcurve2020 6 minutes ago
So, 13 years ago LP says they're good to go with cost issues and profitability with a vaccine showing good results and practically no side effects. Since then the company has lost its retail shareholders 99% plus of their investment and gone into hiding. BioHarm says management is doing a great jo
NWBO
Lolo12 Lolo12 6 minutes ago
He’s working with the garbage dogs.for $2.00 an hour what a lowlife
WDLF
maperatpogi maperatpogi 6 minutes ago
Your enz experienced you have doesn’t bode well here. STFU.

This has the biggest cult following I’ve ever seen on an otc and I was in EN*C to witness that. It takes awhile for these to fully bleed out once people one by one wake up to the fact it’s not what they thought.
IGPK
TRUSTUNITS1000000 TRUSTUNITS1000000 6 minutes ago
0.0001
GBHL

Your Recent History

Delayed Upgrade Clock